glycine has been researched along with Erythermalgia in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with mexiletine reduced the number and severity of pain episodes." | 5.35 | Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off. ( Choi, JS; Dib-Hajj, SD; Han, C; Lin, Z; Tyrrell, L; Wang, X; Waxman, SG; Yang, Y; Zhang, L, 2009) |
| "Treatment with mexiletine reduced the number and severity of pain episodes." | 1.35 | Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off. ( Choi, JS; Dib-Hajj, SD; Han, C; Lin, Z; Tyrrell, L; Wang, X; Waxman, SG; Yang, Y; Zhang, L, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JS | 1 |
| Zhang, L | 1 |
| Dib-Hajj, SD | 1 |
| Han, C | 1 |
| Tyrrell, L | 1 |
| Lin, Z | 1 |
| Wang, X | 1 |
| Yang, Y | 1 |
| Waxman, SG | 1 |
1 other study available for glycine and Erythermalgia
| Article | Year |
|---|---|
Mexiletine-responsive erythromelalgia due to a new Na(v)1.7 mutation showing use-dependent current fall-off.
Topics: Anti-Arrhythmia Agents; Biophysics; Cell Line, Transformed; Child; Chromosomes, Human, Pair 15; Dose | 2009 |